About trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol
trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol (PubChem CID 10334147) has the molecular formula C19H27NO
and a molecular weight of 285.43 g/mol. Its IUPAC name is trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol.
Analyze trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol?
The IUPAC name of trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol (CID 10334147) is trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol.
What is the SMILES notation for trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol?
The canonical SMILES for trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol is O[C@@H]1CCCC[C@H]1N1CCC2(CCc3ccccc32)CC1.
What is the InChIKey of trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol?
The InChIKey is OZRJHGKKLPXGID-QZTJIDSGSA-N. The full InChI is InChI=1S/C19H27NO/c21-18-8-4-3-7-17(18)20-13-11-19(12-14-20)10-9-15-5-1-2-6-16(15)19/h1-2,5-6,17-18,21H,3-4,7-14H2/t17-,18-/m1/s1.
What are the key properties of trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol?
trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol has a molecular weight of 285.43 g/mol, XLogP of 3.27, 1 rotatable bonds, 1 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1R,2R)-2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylcyclohexan-1-ol is sourced from PubChem (CID 10334147), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).